X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (832) 832
Newsletter (113) 113
Publication (113) 113
Newspaper Article (27) 27
Book Review (25) 25
Conference Proceeding (21) 21
Book Chapter (8) 8
Transcript (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
carfilzomib (846) 846
multiple myeloma (510) 510
index medicus (501) 501
humans (403) 403
bortezomib (391) 391
oncology (304) 304
hematology (268) 268
multiple myeloma - drug therapy (222) 222
dexamethasone (192) 192
lenalidomide (189) 189
single-agent carfilzomib (168) 168
open-label (139) 139
proteasome inhibitors (138) 138
research (138) 138
cancer (136) 136
male (135) 135
female (126) 126
care and treatment (120) 120
antineoplastic agents - therapeutic use (115) 115
low-dose dexamethasone (114) 114
proteasome inhibitor (110) 110
therapy (110) 110
drug therapy (105) 105
stem-cell transplantation (105) 105
pharmacology & pharmacy (102) 102
aged (98) 98
multiple myeloma - pathology (97) 97
middle aged (95) 95
animals (90) 90
antineoplastic combined chemotherapy protocols - therapeutic use (89) 89
treatment outcome (89) 89
proteasome inhibitors - therapeutic use (87) 87
ixazomib (86) 86
multiple-myeloma (86) 86
oligopeptides - therapeutic use (85) 85
daratumumab (84) 84
survival (79) 79
apoptosis (78) 78
pomalidomide (78) 78
proteasome inhibitors - pharmacology (77) 77
antineoplastic agents - pharmacology (71) 71
combination (69) 69
oligopeptides - administration & dosage (69) 69
patients (68) 68
proteasome (68) 68
clinical trials (65) 65
oligopeptides - pharmacology (65) 65
chemotherapy (63) 63
lenalidomide plus dexamethasone (62) 62
thalidomide - analogs & derivatives (62) 62
cell line, tumor (61) 61
adult (60) 60
irreversible inhibitor (60) 60
relapse (60) 60
thalidomide (60) 60
analysis (59) 59
medical research (59) 59
oligopeptides - adverse effects (59) 59
refractory multiple-myeloma (58) 58
antineoplastic agents - adverse effects (55) 55
article (55) 55
multiple myeloma - mortality (54) 54
diseases (51) 51
elotuzumab (50) 50
recurrence (50) 50
multiple myeloma - therapy (49) 49
proteasome inhibitors - adverse effects (49) 49
pharmacokinetics (48) 48
aged, 80 and over (46) 46
medicine, experimental (46) 46
transplantation (46) 46
health aspects (45) 45
medicine & public health (45) 45
stem cells (45) 45
dosage and administration (43) 43
myeloma (43) 43
proteasome endopeptidase complex - metabolism (42) 42
dose-response relationship, drug (41) 41
review (41) 41
antitumor-activity (40) 40
hematology, oncology and palliative medicine (40) 40
immunotherapy (40) 40
toxicity (39) 39
drug approval (38) 38
drug resistance, neoplasm (38) 38
proteasome inhibitor carfilzomib (38) 38
reports (38) 38
antineoplastic agents - administration & dosage (37) 37
chemistry, medicinal (37) 37
dexamethasone - administration & dosage (37) 37
in-vitro (37) 37
multiple myeloma - diagnosis (37) 37
nf-kappa-b (37) 37
peripheral neuropathy (37) 37
proteasome inhibitors - administration & dosage (37) 37
proteins (37) 37
cells (36) 36
clinical trials as topic (36) 36
inhibitors (36) 36
development and progression (35) 35
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (961) 961
German (8) 8
Russian (3) 3
Czech (2) 2
Polish (2) 2
Spanish (2) 2
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4729 - 4729
Abstract Introduction: Multiple myeloma (MM) is a rare disease with an estimated annual prevalence of 5.3 per 100,000 persons in Japan (Center for Cancer... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 5395 - 5395
Abstract Introduction: Despite the enormous progress in MM therapy brought about by the rapid development of many novel agents, many patients end up with... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5847 - 5847
Abstract Background and Aim: The incidence and outcomes of patients with cancer diagnoses are reported annually as SEERs in few but not all countries. Clinical... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5651 - 5651
Abstract Introduction Multiple myeloma (MM) is considered an incurable disease. However, during the last years the survival has improved, partly due to the... 
Journal Article
American Journal of Hematology, ISSN 0361-8609, 08/2019, Volume 94, Issue 8, pp. E215 - E216
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4781 - 4781
Abstract Background: Recent introductions of multiple myeloma (MM) chemotherapy agents have improved response and survival rates, yet substantial unmet... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2100 - 2100
Abstract Background: The substantial improvement in clinical outcomes for patients with multiple myeloma (MM) conferred by proteasome inhibitors (PIs),... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 723 - 723
Abstract Introduction: We employed a customized Multiple Myeloma (MM) specific Mutation-Panel (M3 P) to screen a homogenous cohort of refractory MM (rMM)... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1449 - 1449
Abstract The risk of venous thromboembolism (VTE) is increased in individuals with cancer, particularly in those with multiple myeloma. The immunomodulatory... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2244 - 2244
Abstract Introduction Compliance with Multiple Myeloma (MM) recommendations regarding diagnosis and treatment is highly variable worldwide, outside clinical... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2086 - 2086
Abstract Introduction: Patients' individual preferences for specific treatment attributes are an important factor to consider in treatment decisions. This area... 
Journal Article
Hematological Oncology, ISSN 0278-0232, 06/2019, Volume 37, Issue S2, pp. 510 - 511
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e20049 - e20049
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 2, pp. 142 - 152
Journal Article
Pharmaceutical Technology Europe, ISSN 1753-7967, 08/2019, Volume 31, Issue 8, p. 38
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2013, Volume 19, Issue 8, pp. 2248 - 2256
Journal Article
ONCOLOGY RESEARCH AND TREATMENT, ISSN 2296-5270, 04/2017, Volume 40, Issue 4, pp. 226 - 227
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.